Tandem Diabetes Care (TNDM) Long-Term Investments (2014 - 2026)

Tandem Diabetes Care (TNDM) has reported Long-Term Investments for 6 consecutive years, with $132.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Investments rose 95.63% year-over-year to $132.3 million; the trailing twelve-month figure through Jun 2026 stood at $132.3 million (up 95.63% YoY), and the FY2025 full-year result was $60.4 million, down 18.98% from the prior year.
• Long-Term Investments rose to $132.3 million in Q2 2026 per TNDM's latest filing, from $56.5 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $132.3 million in Q2 2026 and bottomed at $56.5 million in Q1 2026.
• Historically, Long-Term Investments has averaged $75.3 million across 3 years, with a median of $67.6 million in 2025.
• The widest YoY moves for Long-Term Investments: up 95.63% in 2026, down 20.43% in 2026.
• Over 3 years, Long-Term Investments stood at $74.5 million in 2024, then dropped by 18.98% to $60.4 million in 2025, then jumped by 119.04% to $132.3 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $132.3 million, $56.5 million, and $60.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.